(76 days)
Not Found
No
The device description details a chemical and physical process for analyzing sperm concentration, relying on colorimetric results compared to a control, with no mention of computational analysis, algorithms, or learning processes.
No
The device is an in vitro diagnostic test kit used to aid in the determination of male infertility by analyzing sperm concentration; it does not treat or prevent any condition.
Yes
The device is described as a "semi-quantitative test for the rapid analysis of sperm concentration to aid in the determination of male infertility," which directly indicates its purpose is to provide information for diagnosis or to rule out a particular condition.
No
The device description clearly outlines a physical test kit containing components like collection cups, pipettes, test cassettes, and reagents, indicating it is a hardware-based in vitro diagnostic device, not software only.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use explicitly states it's a "semi-quantitative test for the rapid analysis of sperm concentration to aid in the determination of male infertility." This is a diagnostic purpose.
- Device Description: The description details a "test kit for the analysis of sperm concentration" and describes components used to "hold, treat, and test collected semen," as well as "reagents intended to stain and wash semen samples." These are all characteristic of in vitro diagnostic devices that analyze biological samples outside the body.
- Mechanism of Action: The test operates by analyzing a semen sample (a biological specimen) using chemical reactions (staining reagent) and physical separation to produce a result indicating sperm concentration. This is a typical in vitro diagnostic process.
- Performance Studies: The document describes clinical evaluations and studies comparing the device's results to a "standard manual microscopic analysis method," which is a common way to validate the performance of an IVD.
- Predicate Device: The mention of a "Predicate Device(s)" with a K number (K915229; Semen Analysis Kit [Humagen Fertility Diagnostics]) strongly indicates that this device is being compared to a previously cleared IVD, a standard part of the regulatory process for IVDs.
All these factors align with the definition and characteristics of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The FertilMARQ™ Test Kit is a semi-quantitative test for the rapid analysis of sperm concentration to aid in the determination of male infertility.
Product codes
GKZ
Device Description
The FertilMARQ™ Test Kit is an in vitro test kit for the analysis of sperm concentration. Each kit provides sufficient components to perform analysis of two separate semen samples in duplicate. The kit contains components intended to hold, treat, and test collected semen (pre-coated collection cups, disposable pipettes, test cassettes), reagents intended to stain and wash semen samples collected on the test cassette. Positive and negative control wells are incorporated into the cassette design. In addition, the package insert and a Test Results form are included in the Kit. The Kit and all components are stored at room temperature. - The test operates by physical separation of sperm from seminal plasma and other semen components after a sample is dropped onto the filter incorporated into the test cassette. The staining reagent (Thiazine Blue) reacts with multiple components present in the differentiated sperm to provide an average signal that is representative of the entire sperm population. Hundreds of thousands to millions of sperm cells are captured and yield a colorimetric result indicating sperm concentration as above or below 20 million/mL (20 M/mL) sperm, as compared to the negative control result, an intrinsic part of the assay.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Of the 162 semen samples evaluated in a three site clinical evaluation, 117 had sperm concentrations equal to or above 20 million/mL and 45 had sperm concentrations below 20 million/mL. 116 out of 117 samples above 20 million/mL were correctly identified as positive and 43 out of 45 samples below 20 million/mL were correctly identified as negative by the FertilMARQ™ Test Kit, based on comparison to light microscopic method result.
In a dilution study at the critical cutoff range, 18 of 19 semen samples with sperm concentrations above 20 million/mL were correctly identified, and 12 of 13 semen samples with sperm concentrations below 20 million/mL were correctly identified, based on comparison to result obtained by the manual light microscopic method. The two other samples were found to be borderline or inconclusive by the FertilMARQ Test Kit.
Reproducibility studies demonstrated that corresponding results were obtained at two sites on the same sample in 48 out of 50 samples, even when semen samples were analyzed 24 hours apart. Each site had one discrepant negative finding where microscopic analysis found concentrations over 20 million/mL. Each laboratory testing the 50 samples had an overall accuracy of 97.5%.
Intra-laboratory testing at one of the clinical evaluation sites resulted in 101 of 102 samples tested having concordant results when the same semen sample was tested by two separate operators.
Key Metrics
Sensitivity = 98%; Specificity = 98%; Accuracy = 98%; Positive predictive Value = 99%; and Negative predictive value = 96%.
Predicate Device(s)
Semen Analysis Kit [Humagen Fertility Diagnostics] (K915229, 08/30/94)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 864.5220 Automated differential cell counter.
(a)
Identification. An automated differential cell counter is a device used to identify one or more of the formed elements of the blood. The device may also have the capability to flag, count, or classify immature or abnormal hematopoietic cells of the blood, bone marrow, or other body fluids. These devices may combine an electronic particle counting method, optical method, or a flow cytometric method utilizing monoclonal CD (cluster designation) markers. The device includes accessory CD markers.(b)
Classification. Class II (special controls). The special control for this device is the FDA document entitled “Class II Special Controls Guidance Document: Premarket Notifications for Automated Differential Cell Counters for Immature or Abnormal Blood Cells; Final Guidance for Industry and FDA.”
0
080 17 1998
510(k) Summary
This 510(k) summary is being submitted in accordance with the requirements of 21 CFR 807.92.
| (A) | (1) | Submitter's name: | Embryotech Laboratories, Inc. |
|---|---|---|---|
| Submitter's address: | 323 Andover Street, Wilmington, MA 01887 | ||
| Submitter's telephone number: | (978) 658-4600 | ||
| Contact Person: | Ann D. McGonigle, Regulatory Affairs (508) 358-9114 | ||
| Date Summary Prepared: | September 30, 1998 | ||
| (2) | Trade or proprietary device name: | FertilMARQ™ Test Kit | |
| Common or usual name: | Semen analysis test kit | ||
| Classification name: | Obstetrics/gynecology | ||
| (3) | Legally marketed predicate device: | Semen Analysis Kit [Humagen Fertility Diagnostics] (K915229, 08/30/94) |
(4) Subject device description:
The FertilMARQ™ Test Kit is an in vitro test kit for the analysis of sperm concentration. Each kit provides sufficient components to perform analysis of two separate semen samples in duplicate. The kit contains components intended to hold, treat, and test collected semen (pre-coated collection cups, disposable pipettes, test cassettes), reagents intended to stain and wash semen samples collected on the test cassette. Positive and negative control wells are incorporated into the cassette design. In addition, the package insert and a Test Results form are included in the Kit. The Kit and all components are stored at room temperature. -
The test operates by physical separation of sperm from seminal plasma and other semen components after a sample is dropped onto the filter incorporated into the test cassette. The staining reagent (Thiazine Blue) reacts with multiple components present in the differentiated sperm to provide an average signal that is representative of the entire sperm population. Hundreds of thousands to millions of sperm cells are captured and vield a colorimetric result indicating sperm concentration as above or below 20 million/mL (20 M/mL) sperm, as compared to the negative control result, an intrinsic part of the assay.
(5) Subject device intended use:
The FertilMARQ™ Test Kit is a semi-quantitative test for the rapid analysis of sperm concentration to aid in the determination of male infertility.
(6) Performance data:
Equivalent results are obtained on semen samples analyzed by both the FerrilMAROTM Test Kit and the standard manual microscopic analysis method.
1
510(k) Summary for FertilMARQTM Test Kit page 2
Of the 162 semen samples evaluated in a three site clinical evaluation, 117 had sperm concentrations equal to or above 20 million/mL and 45 had sperm concentrations below 20 million/mL. 116 out of 117 samples above 20 million/mL were correctly identified as positive and 43 out of 45 samples below 20 million/mL were correctly identified as negative by the FertilMARQ™ Test Kit, based on comparison to light microscopic method result. These data demonstrated the FertilMARO™ Test Kit Sensitivity = 98%; Specificity = 98%; Accuracy = 98%; Positive predictive Value = 99%; and Negative predictive value = 96%.
In a dilution study at the critical cutoff range, 18 of 19 semen samples with sperm concentrations above 20 million/mL were correctly identified, and 12 of 13 semen samples with sperm concentrations below 20 million/mL were correctly identified, based on comparison to result obtained by the manual light microscopic method. The two other samples were found to be borderline or inconclusive by the FertilMARQ Test Kit.
Reproducibility studies also demonstrated that corresponding results were obtained at two sites on the same sample in 48 out of 50 samples, even when semen samples were analyzed 24 hours apart. Each site had one discrepant negative finding where microscopic analysis found concentrations over 20 million/mL. Each laboratory testing the 50 samples had an overall accuracy of 97.5%.
Intra-laboratory testing at one of the clinical evaluation sites resulted in 101 of 102 samples tested having concordant results when the same semen sample was tested by two separate operators.
2
Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features the department's emblem, which is a stylized human figure with three faces in profile, representing the department's focus on people. The emblem is positioned to the right of a circular text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA".
10903 New Hampshire Avenue Silver Spring, MD 20993
Embryotech Laboratories, Inc. c/o Ms. Ann D. McGonigle Regulatory Consultant 323 Andover Street Wilmington, MA 01887
JUN 1 5 2012
Re: K983473
Trade/Device Name: FertilMARQTM Test Kit Regulation Number: 21 CFR § 864.5220 Regulation Name: Automated differential cell counter Regulatory Class: Class II Product Code: GKZ Date: September 30, 1998 Received: October 2, 1998
Dear Ms. McGonigle:
This letter corrects our substantially equivalent letter of December 17, 1998.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of
3
Page 2 - Ms. Ann D. McGonigle
medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Maria M. Chan, Ph.D. Director Division of Immunology and Hematology Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
4
C. Indications for use of the Device
Page 1 of 1
510(k) Number): Not known K983473
FertilMARQ™ Test Kit Device Name:
Indications for Use:
(
The FertilMARQ™ Test Kit is a semi-quantitative test for the rapid analysis of sperm I he Fermination to aid in the determination of male infertility.
(Please do not write below this line-continue on another page if needed)
- ギ *
Concurrence of CDRH, Office of Device Evaluation (ODE)
Peter E. Makeri
(D'Vision Sign-Off)
Division of Clinical Laboratory Devices
510(k) Number K983473
Over-the-Counter Use Prescription Use_X Or (Per 21 CFR 801.109) (Optional Format 1-2-96)